Cancellations by sponsors

This database shows cancellations of Australian Register of Therapeutic Goods entries requested by sponsors.

Last updated

23 December 2025

Find out more at Information about cancellations requested by the sponsor - regulatory actions.

Filters applied:

2017

Clear all

7409 result(s) found, displaying 7376 to 7400

Bard Australia Pty Ltd - LifeStar Vascular Stent System - Iliac artery stent Cancelled under s41GL(d)

17 January 2017

Cancellation by sponsor

Requested by Bard Australia Pty Ltd
Bard Australia Pty Ltd - LifeStar Vascular Stent System - Iliac artery stent Cancelled under s41GL(d)

17 January 2017

Cancellation by sponsor

Requested by Bard Australia Pty Ltd
Dancor Pty Ltd T/a Boab Medical Technologies Mask, partial rebreathing Cancelled under s41GL(d)

17 January 2017

Cancellation by sponsor

Requested by Dancor Pty Ltd T/a Boab Medical Technologies
Dancor Pty Ltd T/a Boab Medical Technologies Mask, partial rebreathing Cancelled under s41GL(d)

17 January 2017

Cancellation by sponsor

Requested by Dancor Pty Ltd T/a Boab Medical Technologies
Medtronic Australasia Pty Ltd - Lead, pacemaker, implantable, endocardial Cancelled under s41GL(d)

17 January 2017

Cancellation by sponsor

Requested by Medtronic Australasia Pty Ltd
Medtronic Australasia Pty Ltd - Lead, pacemaker, implantable, endocardial Cancelled under s41GL(d)

17 January 2017

Cancellation by sponsor

Requested by Medtronic Australasia Pty Ltd
PHARMACY HEALTH ORANGE EFFERVESCENT ELECTROLYTE TABLETS Cancelled under s30(1)(c)

17 January 2017

Cancellation by sponsor

Requested by Neo Health (OTC) Pty Ltd
PHARMACY HEALTH ORANGE EFFERVESCENT ELECTROLYTE TABLETS Cancelled under s30(1)(c)

17 January 2017

Cancellation by sponsor

Requested by Neo Health (OTC) Pty Ltd
PRICELINE PHARMACY ORANGE EFFERVESCENT ELECTROLYTE TABLETS Cancelled under s30(1)(c)

17 January 2017

Cancellation by sponsor

Requested by Neo Health (OTC) Pty Ltd
PRICELINE PHARMACY ORANGE EFFERVESCENT ELECTROLYTE TABLETS Cancelled under s30(1)(c)

17 January 2017

Cancellation by sponsor

Requested by Neo Health (OTC) Pty Ltd
GLYCOPYRROLATE MYX glycopyrrolate 0.2 mg/1 mL injection ampoules Cancelled under s30(1)(c) of the Act

12 January 2017

Cancellation by sponsor

Requested by Accord Healthcare Pty Ltd
GLYCOPYRROLATE MYX glycopyrrolate 0.6 mg/3 mL injection ampoules Cancelled under s30(1)(c) of the Act

12 January 2017

Cancellation by sponsor

Requested by Accord Healthcare Pty Ltd
APO-PARACETAMOL/CODEINE 500/30 paracetamol 500 mg and codeine phosphate hemihydrate 30 mg tablet blister pack Cancelled under s30(1)(c) of the Act

11 January 2017

Cancellation by sponsor

Requested by Aspen Pharma Pty Ltd
APO-PARACETAMOL/CODEINE 500/30 paracetamol 500 mg and codeine phosphate hemihydrate 30 mg tablet blister pack Cancelled under s30(1)(c) of the Act

11 January 2017

Cancellation by sponsor

Requested by Aspen Pharma Pty Ltd
By Nature FX-3 Advance Cancelled under s30(1)(c) of the Act

11 January 2017

Cancellation by sponsor

Requested by Canvale Holdings Pty Ltd
Camsen Forte Green Tea Tablets 14000mg Cancelled under s30(1)(c) of the Act

11 January 2017

Cancellation by sponsor

Requested by Canvale Holdings Pty Ltd
GUARDIAN HEARTBURN RELIEF ranitidine 150mg (as hydrochloride) tablet blister pack Cancelled under s30(1)(c) of the Act

11 January 2017

Cancellation by sponsor

Requested by Aspen Pharma Pty Ltd
iNova Pharmaceuticals Australia Pty Ltd Lens, intraocular, posterior chamber Cancelled under s41GL(d) of the Act

11 January 2017

Cancellation by sponsor

Requested by iNova Pharmaceuticals Australia Pty Ltd
MD Solutions Australasia Pty Ltd - VariStrand - Radionuclide system, therapeutic, brachytherapy, manual Cancelled under s41GL(d) of the Act

11 January 2017

Cancellation by sponsor

Requested by MD Solutions Australasia Pty Ltd
Protocel for Children Cancelled under s30(1)(c) of the Act

11 January 2017

Cancellation by sponsor

Requested by Canvale Holdings Pty Ltd
ANAPEN 150 adrenaline (epinephrine) 150 microgram/0.3mL injection syringe auto-injector Cancelled under s30(1)(c) of the Act

6 January 2017

Cancellation by sponsor

Requested by Link Medical Products Pty Ltd T/A Link Pharmaceuticals
ANAPEN 300 adrenaline (epinephrine) 300 microgram/0.3mL injection syringe auto-injector Cancelled under s30(1)(c) of the Act

6 January 2017

Cancellation by sponsor

Requested by Link Medical Products Pty Ltd T/A Link Pharmaceuticals
ANAPEN 500 adrenaline (epinephrine) 500 micrograms in 0.3mL injection syringe auto-injector Cancelled under s30(1)(c) of the Act

6 January 2017

Cancellation by sponsor

Requested by Link Medical Products Pty Ltd T/A Link Pharmaceuticals
CANDESARTAN RBX candesartan cilexetil 4 mg tablet blister pack Cancelled under s30(1)(c) of the Act

6 January 2017

Cancellation by sponsor

Requested by Ranbaxy Australia Pty Ltd
N Stenning & Co Pty Ltd - Applier Cancelled under s41GL(d) of the Act

6 January 2017

Cancellation by sponsor

Requested by N Stenning & Co Pty Ltd

Last updated

23 December 2025

Sub menu

Product regulation

Safety and shortages

Resources and guidance

Business services

Cancellations by sponsors

Filter results

Decision type

Date of effect

Bard Australia Pty Ltd - LifeStar Vascular Stent System - Iliac artery stent Cancelled under s41GL(d)

Bard Australia Pty Ltd - LifeStar Vascular Stent System - Iliac artery stent Cancelled under s41GL(d)

Dancor Pty Ltd T/a Boab Medical Technologies Mask, partial rebreathing Cancelled under s41GL(d)

Dancor Pty Ltd T/a Boab Medical Technologies Mask, partial rebreathing Cancelled under s41GL(d)

Medtronic Australasia Pty Ltd - Lead, pacemaker, implantable, endocardial Cancelled under s41GL(d)

Medtronic Australasia Pty Ltd - Lead, pacemaker, implantable, endocardial Cancelled under s41GL(d)

PHARMACY HEALTH ORANGE EFFERVESCENT ELECTROLYTE TABLETS Cancelled under s30(1)(c)

PHARMACY HEALTH ORANGE EFFERVESCENT ELECTROLYTE TABLETS Cancelled under s30(1)(c)

PRICELINE PHARMACY ORANGE EFFERVESCENT ELECTROLYTE TABLETS Cancelled under s30(1)(c)

PRICELINE PHARMACY ORANGE EFFERVESCENT ELECTROLYTE TABLETS Cancelled under s30(1)(c)

GLYCOPYRROLATE MYX glycopyrrolate 0.2 mg/1 mL injection ampoules Cancelled under s30(1)(c) of the Act

GLYCOPYRROLATE MYX glycopyrrolate 0.6 mg/3 mL injection ampoules Cancelled under s30(1)(c) of the Act

APO-PARACETAMOL/CODEINE 500/30 paracetamol 500 mg and codeine phosphate hemihydrate 30 mg tablet blister pack Cancelled under s30(1)(c) of the Act

APO-PARACETAMOL/CODEINE 500/30 paracetamol 500 mg and codeine phosphate hemihydrate 30 mg tablet blister pack Cancelled under s30(1)(c) of the Act

By Nature FX-3 Advance Cancelled under s30(1)(c) of the Act

Camsen Forte Green Tea Tablets 14000mg Cancelled under s30(1)(c) of the Act

GUARDIAN HEARTBURN RELIEF ranitidine 150mg (as hydrochloride) tablet blister pack Cancelled under s30(1)(c) of the Act

iNova Pharmaceuticals Australia Pty Ltd Lens, intraocular, posterior chamber Cancelled under s41GL(d) of the Act

MD Solutions Australasia Pty Ltd - VariStrand - Radionuclide system, therapeutic, brachytherapy, manual Cancelled under s41GL(d) of the Act

Protocel for Children Cancelled under s30(1)(c) of the Act

ANAPEN 150 adrenaline (epinephrine) 150 microgram/0.3mL injection syringe auto-injector Cancelled under s30(1)(c) of the Act

ANAPEN 300 adrenaline (epinephrine) 300 microgram/0.3mL injection syringe auto-injector Cancelled under s30(1)(c) of the Act

ANAPEN 500 adrenaline (epinephrine) 500 micrograms in 0.3mL injection syringe auto-injector Cancelled under s30(1)(c) of the Act

CANDESARTAN RBX candesartan cilexetil 4 mg tablet blister pack Cancelled under s30(1)(c) of the Act

N Stenning & Co Pty Ltd - Applier Cancelled under s41GL(d) of the Act

Is there anything wrong with this page?

Site notifications

Cancellations by sponsors

Filter results

Decision type

Date of effect

Is there anything wrong with this page?